ESG

A pioneering project offers a new model for tackling homelessness, combining private innovation with community expertise to provide dignity and stability.

The Asian Heritage Foundation goes national, partnering with the NCAC to unite communities and intensify the fight against anti-Asian hate across Canada.

Chinese beverage leader Walovi inks deals in 10 nations, leveraging health trends and a bold strategy to expand its plant-based empire worldwide.

A novel medical food for IBS shows remarkable efficacy in new studies, exceeding FDA benchmarks for pain relief and solving the long-standing issue of taste.

As enterprises move from AI experimentation to execution, the focus is shifting to a critical, overlooked element: the data. Here's why.

Wisk Aero's second Gen 6 eVTOL has taken flight, a move set to fast-track its autonomous flight program and intensify the race for certified air taxis.

A major investment in natural killer cell immunotherapy aims to revolutionize treatment for Canada's most fatal women's cancer after decades of stagnation.

Morningstar's investment chief joins a health AI firm, signaling a new era where financial modeling principles could unlock preventative wellness for millions.

LANGLARA, a new Lantus biosimilar, gains FDA approval, promising more affordable diabetes care. But it faces a tough fight in a competitive market.

The new Gibco CTS DynaXS bioreactor aims to unlock scalable production, making life-saving cell therapies more accessible and affordable for patients.

One in five mothers face perinatal mental health disorders, but most never get help. An inside look at the systemic failures and the fight for a lifeline.

Scott Drennan takes the helm at Otto Aerospace, tasked with turning the visionary, ultra-efficient Phantom 3500 jet from concept to certified reality.

A new, independently validated study proves a curated digital health network can slash healthcare costs and improve outcomes, setting a new bar for ROI.

Beyond the ABCs, Sesame Workshop is expanding its global initiative to equip children and families with crucial tools for emotional well-being.

The prepared foods brand is launching in 2,750 stores, capitalizing on consumer demand for convenience and retailer needs for turnkey deli solutions.

A new testing platform from Armatus Bio aims to break a major bottleneck in gene therapy, promising faster paths to cures for rare neuromuscular diseases.

Standard skin checks often miss deadly melanomas. An Arizona dermatologist sounds the alarm on a critical detection gap and a tool that could save lives.

A new report shows CMOs wield unprecedented influence and AI, yet a majority feel their role is structurally flawed, hindering their path to success.

The clinical-stage biotech adds seasoned veterans from Eli Lilly and Iovance to accelerate its promising DNA Damage Response pipeline toward commercialization.

Valitor's VLTR-559 shows superior durability in preclinical data, potentially slashing wet AMD treatment from monthly injections to just two per year.